|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Molecular classifications of gastric cancers: Novel insights and possible future applications显示文摘Despite some notable advances in the systemic management of gastric cancer(GC), the prognosis of patients with advanced disease remains overall poor and their chance of cure is anecdotic. In a molecularly selected population, a median overall survival of 13.8 mo has been reached with the use of human epidermal growth factor 2(HER2) inhibitors in combination with chemotherapy, which has soon after become the standard of care for patients with HER2-overexpressing GC. Moreover, oncologists have recognized the clinical utility of conceiving cancers as a collection of different molecularlydriven entities rather than a single disease. Several molecular drivers have been identified as having crucial roles in other tumors and new molecular classifications have been recently proposed for gastric cancer as well. Not only these classifications allow the identification of different tumor subtypes with unique features, but also they serve as springboard for the development of different therapeutic strategies. Hopefully, the application of standard systemic chemotherapy, specifictargeted agents, immunotherapy or even surgery in specific cancer subgroups will help maximizing treatment outcomes and will avoid treating patients with minimal chance to respond, therefore diluting the average benefit. In this review, we aim at elucidating the aspects of GC molecular subtypes, and the possible future applications of such molecular analyses. | Silvio Ken Garattini Debora Basile Monica Cattaneo Valentina Fanotto Elena Ongaro Marta Bonotto Francesca V Negri Rosa Berenato Paola Ermacora Giovanni Gerardo Cardellino Mariella Giovannoni Nicoletta Pella Mario Scartozzi Lorenzo Antonuzzo Nicola Silvestris Gianpiero Fasola Giuseppe Aprile | 2017 | World Journal of Gastrointestinal Oncology2017，9，5： | 5 |
| 2 | Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia 显示文摘 | Damiani D Michieli M Ermacora A | 1998 | Leukemia1998，12，8： | 1 |
| 3 | P - glycoprotein(P - gp)and lung resistance - related protein(LRP) expression and function in leukaemic blast cells显示文摘 | Michieli M Damiani D Ermacora A | 1997 | Br J Haematol1997，96，2： | 1 |
| 4 | P-ycoprotein (PGP),lung resistance-related Protein (LRP) and multidrug resistance-associated Protein(MRP) expression in acute promyelocytic leukemia显示文摘 | Damiani D Ermacora A | 2000 | Br J Haematol2000，108，4： | 1 |
| 5 | Multiple familial smooth muscle hamartomas 显示文摘 | Gualandri L Cambiaghi S Ermacora E | 2001 | Pediatr Dermatol2001，18，1： | 1 |
| 6 | Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia显示文摘 | Damiani D Michieli M Ermacora A | 1998 | Leukemia1998，12，8： | 1 |
| 7 | Evaluation of animproved indirect method for the analysis of 3 - MCPD esters based on acid transesterification 显示文摘 | ERMACORA A HRNCIRIK K | 2012 | J Am Oil Chem Soc2012，89，2： | 1 |
| 8 | Di-rect analysis of intact glycidyl fatty acid esters in edibleoils using gas chromatography - mass spectrometry 显示文摘 | STEENBERGEN H ERMACORA A HRNCIRIK K | 2013 | JChromatogr A2013，1313，： | 1 |
| 9 | Liposome-encap sulated dox-orubicin for PGP-related muhidrug re sistance显示文摘 | Michieli M Damiani D Ermacora A | 1999 | Br J Haematol1999，106，： | 1 |
| 10 | Risk of unplanned visits for colorectal cancer outpatients receiving chemotherapy: a case-crossover study显示文摘 | Luisa Foltran Giuseppe Aprile Federica Edith Pisa Paola Ermacora Nicoletta Pella Emiliana Iaiza Elena Poletto Stefania Eufemia Lutrino Micol Mazzer Mariella Giovannoni Giovanni Gerardo Cardellino Fabio Puglisi Gianpiero Fasola | 2014 | Supportive Care in Cancer2014，，9： | 1 |
| 11 | Liposome-encapsulated daunorubicin for PC,P-related muhidrug resistance显示文摘 | Damiani D Ermacora A | 1999 | BrJ Haematol1999，106，1： | 1 |
| 12 | Muhiple familial smooth muscle hamartomas 显示文摘 | Gualandri L Cambiaghi S Ermacora E et aJ | 2001 | Pedialr Oennalol2001，，： | 1 |
| 13 | The ' life cycle' of pear decline phytoplasma in the vector Cacopsylla pyri显示文摘 | Cauraro L Loi N Ermacora P | | 0，，2： | 1 |
| 14 | P - glycoprotein,lung resistance - related protein and multidrug resistance associated protein in denovo acute non -lymphocytic leukaemia: biological and clinical implication 显示文摘 | Michieli M Damiani D Ermacora A etal | 1999 | Br J Heamatol1999，104，： | 1 |
| 15 | A novel method for simultaneous monitoring of2-MCPD,3-MCPD and glycidyl esters in oils and fats显示文摘 | ERMACORA A HRNCIRIK K | 2012 | J Am Oil Chem Soc2012，8，3： | 1 |
| 16 | Influence of oil composition on the formation of fatty acid esters of 2-chloropropane-1,3-diol (2-MCPD) and 3-chloropropane-1,2-diol (3-MCPD) under conditions simulating oil refining显示文摘 | Alessia Ermacora Karel Hrncirik | 2014 | Food Chemistry2014，，： | 1 |
| 17 | Multiple pilomatricomas in Rubinstein Taybi syndrome: a case report显示文摘 | Cambiaghi S Ermacora E Brusasco A | 1994 | Pediatr Dermatol1994，11，1： | 1 |
| 18 | Liposome-encap sulated dox-orubicin for PGP-related muhidrug resistance显示文摘 | Michieli M Damiani D Ermacora A | 1999 | Br J Haematol1999，106，： | 1 |
| 19 | Highlysensitive and specific enzyme-linked immunosorbent assays for GAD65 autoantibodies using a thioredoxin-GAD65 fusion antigen显示文摘 | Valdez SN Ermacora MR | 1997 | J Immunol Methods1997，207，2： | 1 |
| 20 | P-glycoprotein,lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukemias:biological and clinical implications 显示文摘 | Michieli M Dmiani D Ermacora A | 1999 | Br J Haematol1999，104，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员